TipRanks
pc:ely3x

Elysium Therapeutics

1201 E Market St. Suite 604 Akron, OH 44305, US
https://www.elysiumrx.com/
Elysium Therapeutics is an emerging biopharmaceutical company developing treatments to prevent and reverse overdoses caused by highly potent synthetic opioids, with a specific focus on oral fentanyl and nitazenes. The company is advancing SOOPR™, a rapid-onset, long-acting naloxone prodrug rescue therapy, and developing SMART™ and O2P™ product approaches to improve opioid safety and reduce overdose fatalities.

Leadership & Board

Current Number of Employees4
Current LinkedIn Followers288

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$8M
Total Amount Raised$8M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$8M
Latest Funding Amount$8M
Latest Funding RoundConvertible Notes
Latest Funding RoundConvertible Notes
Post-Money Valuation―
Post-Money Valuation―

Employee Trend

Elysium Therapeutics had 4 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
4Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Elysium Therapeutics had 288 followers as of October 12, 2026. The number of followers increased by 0 (0.00%) week-over-week.
288Latest Followers Count
0(0.00%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 28, 2026
Convertible Notes
$7.50M
―

Similar Companies

A snapshot of private companies similar to Elysium Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis